BiotechTube
Home/Azitra/Francisco Salva
FS

Francisco Salva

President and CEO

Azitra

Therapeutic Areas

DermatologyRare DiseasesOncology Supportive Care

Azitra Pipeline

DrugIndicationPhase
ATR-12Netherton SyndromePhase 1
ATR-04EGFR Inhibitor-Associated RashPreclinical / Phase 1
ATR-01Ichthyosis VulgarisPreclinical

Leadership Team at Azitra

TW
Travis Whitfill
Cofounder and Chief Operating Officer
View full Azitra profile